Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

State of the Science Summit - Hematologic Malignancies: Chaired by Catherine E. Lai, MD, MPH

Speakers

  • Catherine E. Lai, MD, MPH | Penn Medicine
  • Elizabeth Olson Hexner, MD | Penn Medicine
  • Pashna N. Mushni, MD | Penn Medicine
  • Daria V. Babushok, MD, PhD | Penn Medicine
  • Ximena Jordan Bruno, MD | Penn Medicine
  • Elise A. Chong, MD | Penn Medicine

Topics

  • Treatment of Patients With Myelofibrosis
  • Current and Future Treatments for Chronic GVHD
  • Treatment Pathways for Patients With PNH
  • Emerging Treatment Standards for MDS
  • Sequencing BTK Inhibitors in CLL
  • Therapeutic Approaches to AML

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Ponatinib in patients with chronic-phase chronic myeloid leukemia and the T315I mutation: 4-year results from OPTIC
Sujith Samarasinghe, MD
Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: A Network Meta-Analysis
Michael R. Grunwald, MD, FACP
Shella Saint Fleur-Lominy, MD, PhD
Manali Kamdar, MD
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD
David L. Porter, MD
Sattva S. Neelapu, MD